Am J Psychiatry

1. HOU Y, Xia H, He T, Zhang B, et al
   N2 Responses in Youths With Psychosis Risk Syndrome and Their Association With Clinical Outcomes: A Cohort Follow-Up Study Based on the Three-Stimulus Visual Oddball Paradigm.
   Am J Psychiatry. 2024 Feb 29:appiajp20221013. doi: 10.1176/appi.ajp.20221013.
   

   >> Share

   
   

   
   Brain Res

2. GAN L, Wang L, Liu H, Wang G, et al
   Based on neural network cascade abnormal texture information dissemination of classification of patients with schizophrenia and depression.
   Brain Res. 2024 Feb 23:148819. doi: 10.1016/j.brainres.2024.148819.
   

   >> Share

   
   

   
   J Clin Psychiatry

3. CITROME L, Yagoda S, Bidollari I, Wang M, et al
   Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophre
   J Clin Psychiatry. 2024;85:23m15095.
   

   >> Share

   
   

   
   J Clin Psychopharmacol

4. NAGANO M, Susuta Y, Masui H, Watanabe Y, et al
   Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder: Primary Results and Post Hoc Analyses of the J-KINECT Study.
   J Clin Psychopharmacol. 2024;44:107-116.
   

   >> Share

   
   

   
   J Nerv Ment Dis

5. EKINCI O, Koyuncu AN
   Assessment of the Readability and Quality of Online Information for Patients and Their Families Regarding Schizophrenia.
   J Nerv Ment Dis. 2024 Jan 25. doi: 10.1097/NMD.0000000000001763.
   

   >> Share

   
   
6. TSCHOKE S, Knauer Y, Flammer E, Usemann P, et al
   Psychotic Experiences and Daily Functioning in Borderline Personality Disorder and Schizophrenia.
   J Nerv Ment Dis. 2024;212:187-189.
   

   >> Share

   
   

   
   Neuropsychopharmacology

7. CABRERA-MENDOZA B, Aydin N, Fries GR, Docherty AR, et al
   Estimating the direct effects of the genetic liabilities to bipolar disorder, schizophrenia, and behavioral traits on suicide attempt using a multivariable Mendelian randomization approach.
   Neuropsychopharmacology. 2024 Feb 23. doi: 10.1038/s41386-024-01833.
   

   >> Share

   
   

   
   PLoS One

8. ROSADO D, Intriago B, Loor E, Alcivar F, et al
   Associations between Toxoplasma gondii seropositivity and psychopathological manifestations in schizophrenic patients: A single-center study from Ecuador.
   PLoS One. 2024;19:e0297523.
   

   >> Share

   
   

   
   Psychiatry Res

9. KWAK PP, Ibarra C, Hernandez A, Carrasco J, et al
   Differences in metabolic biomarkers in people with schizophrenia who are of Mexican descent compared to non-Hispanic whites.
   Psychiatry Res. 2024;334:115788.
   

   >> Share

   
   
10. QIN K, Yu Y, Cai H, Li J, et al
    Effectiveness of mindfulness-based intervention in schizophrenia: A meta-analysis of randomized controlled trials.
    Psychiatry Res. 2024;334:115808.
    

    >> Share

    
    

    
    Psychol Med

11. ROBINSON N, Ploner A, Leone M, Lichtenstein P, et al
    Environmental risk factors for schizophrenia and bipolar disorder from childhood to diagnosis: a Swedish nested case-control study.
    Psychol Med. 2024 Mar 1:1-10. doi: 10.1017/S0033291724000266.
    

    >> Share

    
    
12. CORSI-ZUELLI F, Quattrone D, Ragazzi TCC, Loureiro CM, et al
    Transdiagnostic dimensions of symptoms and experiences associated with immune proteins in the continuity of psychosis.
    Psychol Med. 2024 Feb 28:1-13. doi: 10.1017/S0033291724000199.
    

    >> Share

    
    

    
    Schizophr Res

13. ISAYEVA U, Manchia M, Collu R, Primavera D, et al
    Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data.
    Schizophr Res. 2024;266:197-204.
    

    >> Share

    
    
14. SAVILL M, Loewy RL, Niendam TA, Porteus AJ, et al
    The diagnostic accuracy of screening for psychosis spectrum disorders in behavioral health clinics integrated into primary care.
    Schizophr Res. 2024;266:190-196.
    

    >> Share

    
    
15. CABUK T, Sevim N, Mutlu E, Yagcioglu AEA, et al
    Natural language processing for defining linguistic features in schizophrenia: A sample from Turkish speakers.
    Schizophr Res. 2024;266:183-189.
    

    >> Share

    
    
16. ZHAO W, Cannon TD
    Moral learning and positive schizotypy: Social cognitive mechanisms in psychosis- proneness.
    Schizophr Res. 2024;266:156-164.
    

    >> Share

    
    
17. BAKER SC, Messer SJ, Girgis RR, Horga G, et al
    Prior overweighting relates to delusional ideation in individuals at clinical high-risk for psychosis.
    Schizophr Res. 2024;266:153-155.
    

    >> Share

    
    
18. TIBIRICA L, Kohn J, Patapoff M, Williams AP, et al
    Acculturation and clinical symptoms of schizophrenia among Latine adults in the United States.
    Schizophr Res. 2024;266:145-152.
    

    >> Share

    
    
19. PENG Z, Li Q, Liu X, Zhang H, et al
    A new schizophrenia screening instrument based on evaluating the patient's writing.
    Schizophr Res. 2024;266:127-135.
    

    >> Share

    
    
20. MAKIPELTO V, Tuulio-Henriksson A, Hakulinen C, Niemela S, et al
    Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophrenia.
    Schizophr Res. 2024;266:118-126.
    

    >> Share

    
    
21. BALLERINI M, Magnani F, Amorosi S, Dell'Anna C, et al
    Anomalous Self-Experiences are predictive of social dysfunction in people with schizophrenia.
    Schizophr Res. 2024;266:116-117.
    

    >> Share

    
    
22. TORREGROSSA LJ, Liu J, Armstrong K, Heckers S, et al
    Interplay between childhood trauma, bodily self-disturbances, and clinical phenomena in schizophrenia spectrum disorders: A network analysis.
    Schizophr Res. 2024;266:107-115.
    

    >> Share

    
    
23. PERALTA V, de Jalon EG, Moreno-Izco L, Peralta D, et al
    The effect of anticholinergic burden of psychiatric medications on major outcome domains of psychotic disorders: A 21-year prospective cohort study.
    Schizophr Res. 2024;264:386-393.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share